Partner Content Partner Content Formedix Expedites Clinical Trial Build with New Cloud Clini... New cloud clinical MDR to expedite trial design & build
Partner Content Partner Content 3 Considerations for Pharma Brand Strategy Success How to reach the right people - with or without cookies
Events Partner Content 9th PREDiCT: Tumor Models Cell Therapy Summit With high stakes to satisfy unmet patient needs, cell therapy is a promising but challenging field of oncology. There is a crucial need to progress candidates from bench to bedside.
Events Partner Content RBQM Live: The Definitive Guide to RBQM for Experts and Begi... RBQM Live two-day virtual event May 20-21
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.